Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice

Chun-Gen Xing; Bao-Song Zhu; Xiao-Qing Fan; Hui-Hui Liu; Xun Hou; Kui Zhao; Zheng-Hong Qin; Wang-Xue Chen
October 2009
World Journal of Gastroenterology;10/28/2009, Vol. 15 Issue 40, p5044
Academic Journal
AIM: To investigate the effects of class I phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 on the invasiveness and related mechanisms of implanted tumors of SGC7901 human gastric carcinoma cells in nude mice. METHODS: Nude mice were randomly divided into model control groups and LY294002 treatment groups. On days 5, 10 and 15 after treatment, the inhibitory rate of tumor growth, pathological changes in tumor specimens, expression levels of matrix metalloproteinase (MMP)-2, MMP-9, CD34 [representing microvessel density (MVD)] and vascular endothelial growth factor (VEGF), as well as apoptosis indexes in tumor samples were observed. RESULTS: In this study, we showed that treating the tumors with LY294002 could significantly inhibit carcinoma growth by 11.3%, 29.4% and 36.7%, after 5, 10 and 15 d, respectively, compared to the control group. Hematoxylin & eosin staining indicated that the rate of inhibition increased progressively (23.51% ± 3.11%, 43.20% ± 3.27% and 63.28% ± 2.10% at 5, 10 and 15 d, respectively) along with apoptosis. The expression of MMP-2 was also downregulated (from 71.4% ± 1.6% to 47.9% ± 0.7%, 31.9% ± 0.9% and 7.9% ± 0.7%). The same effects were observed in MMP-9 protein expression (from 49.4% ± 1.5% to 36.9% ± 0.4%, 23.5% ± 0.9% and 7.7% ± 0.6%), the mean MVD (from 51.2% ± 3.1% to 41.9% ± 1.5%, 30.9% ± 1.7% and 14.9% ± 0.8%), and the expression of VEGF (from 47.2% ± 3.1% to 25.9% ± 0.5%, 18.6% ± 1.2% and 5.1% ± 0.9%) by immunohistochemical staining. CONCLUSION: The class I PI3K inhibitor LY294002 could inhibit the invasiveness of gastric cancer cells by downregulating the expression of MMP-2, MMP-9, and VEGF, and reducing MVD.


Related Articles

  • Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model. Pan, Hung-Chuan; Lai, De-Wei; Lan, Keng-Hsin; Shen, Chin-Chang; Wu, Sheng-Mao; Chiu, Chien-Shan; Wang, Keh-Bin; Sheu, Meei-Ling // Carcinogenesis;Nov2013, Vol. 34 Issue 11, p2568 

    Honokiol is known to suppress the growth of cancer cells; however, to date, its antiperitoneal dissemination effects have not been studied in an orthotopic mouse model. In the present study, we evaluated the antiperitoneal dissemination potential of Honokiol in an orthotopic mouse model and...

  • An orthotopic nude mouse model for preclinical research of gastric cardia cancer. Bhargava, Sarah; Hotz, Birgit; Buhr, Heinz J.; Hotz, Hubert G. // International Journal of Colorectal Disease;Jan2009, Vol. 24 Issue 1, p31 

    A clinically relevant animal model for cancer of the esophagogastric junction does not exist. This study aimed to establish an orthotopic mouse model for human gastric cancer of the distal stomach and the gastric cardia. Human gastric cancer cell lines AGS, MKN-45, and NCI-N87 were injected...

  • Adenovirus-mediated siRNA inhibited survivin gene expression induces tumor cell apoptosis in nude mice. Kun Yin; Qiaoqiao Liu; Song Zhu; Ge Yan // BioScience Trends;Dec2008, Vol. 2 Issue 6, p231 

    In order to research the survivin gene's action on an animal tumor, we used an adenovirus-mediated siRNA system to inhibit the expression of survivin in an animal model of hepatocarcinoma using nude mice. We constructed a hepatocarcinoma model with nude mice using the hepatocarcinoma cell line...

  • Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Chang, C.; Lee, S. O.; Yeh, S.; Chang, T. M. // Oncogene;6/19/2014, Vol. 33 Issue 25, p3225 

    The androgen receptor (AR) is expressed in many cell types and the androgen/AR signaling has been found to have important roles in modulating tumorigenesis and metastasis in several cancers including prostate, bladder, kidney, lung, breast and liver. However, whether AR has differential roles in...

  • Inflammation and cancer: macrophage migration inhibitory factor (MIF)—the potential missing link. Conroy, H.; Mawhinney, L.; Donnelly, S. C. // QJM: An International Journal of Medicine;Nov2010, Vol. 103 Issue 11, p831 

    Macrophage migration inhibitory factor (MIF) was the original cytokine, described almost 50 years ago and has since been revealed to be an important player in pro-inflammatory diseases. Recent work using MIF mouse models has revealed new roles for MIF. In this review, we present an increasing...

  • A Specific Nuclear DNA Background Is Required for High Frequency Lymphoma Development in Transmitochondrial Mice with G13997A mtDNA. Hashizume, Osamu; Yamanashi, Haruka; Taketo, Makoto M.; Nakada, Kazuto; Hayashi, Jun-Ichi // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    We previously found that mouse mitochondrial DNA (mtDNA) with a G13997A mutation (G13997A mtDNA) controls not only the transformation of cultured lung carcinoma cells from poorly metastatic into highly metastatic cells, but also the transformation of lymphocytes into lymphomas in living C57BL/6...

  • MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells. Lee, Yong Joo; Han, Myoung-Eun; Baek, Su-Jin; Kim, Seon-Young; Oh, Sae-Ock // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    MED30 is an essential member of the mediator complex that forms a hub between transcriptional activators and RNA polymerase II. However, the expressions and roles of MED30 have been poorly characterized in cancer. In this study, we examined the functional roles of MED30 during gastric cancer...

  • Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype. Abdelkarim, Mohamed; Vintonenko, Nadejda; Starzec, Anna; Robles, Aniela; Aubert, Julie; Martin, Marie-Laure; Mourah, Samia; Podgorniak, Marie-Pierre; Rodrigues-Ferreira, Sylvie; Nahmias, Clara; Couraud, Pierre-Olivier; Doliger, Christelle; Sainte-Catherine, Odile; Peyri, Nicole; Lei Chen; Mariau, Jérémie; Etienne, Monique; Perret, Gerard-Yves; Crepin, Michel; Poyet, Jean-Luc // PLoS ONE;2011, Vol. 6 Issue 8, p1 

    Introduction: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM) environment to this phenomenon, we isolated ECM surrogate...

  • PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis. Guo, Q.; Su, N.; Zhang, J.; Li, X.; Miao, Z.; Wang, G.; Cheng, M.; Xu, H.; Cao, L.; Li, F. // Oncogene;6/19/2014, Vol. 33 Issue 25, p3277 

    Superior cervical ganglia 10 (SCG10), as a microtubule (MT) destabilizer, maintains MT homeostasis and has a critical role in neuronal development, but Its function in tumorigenesis has not been characterized. In the present study, we demonstrated that p21-activated kinase 4 (PAK4)-mediated...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics